On day 20, melanoma in the PBS control group had grown to be 5 × 5 mm, while IFN-γ treatment kept the original tumour size as observed on day 5, further suggesting that IFN-γ induces TRC dormancy in vivo (Fig. 2d). The gene discussed is IFNG; the disease is neoplasm.